Glenmark Life Sciences

Stock Radar: Vishal Mega Mart, Mobikwik, JSW Energy, Va Tech Wabag, Pondy Oxides, Aurobindo Pharma in focus on Wednesday

Stocks like Aurobindo Pharma, Jindal Saw, Route Mobile, Gujarat Industries Power Co, Aditya Birla Real Estate, Exide Industries, Sonata Software, Sun TV Network, LTIMindtree, Hampton Sky Realty, Aditya Birla Sun Life AMC, and Restaurant Brands Asia will also be in focus on December 18.

Glenmark Life Standalone September 2024 Net Sales at Rs 506.88 crore, down 14.86% Y-o-Y

Under a new owner, Glenmark Life Sciences aims to shed past constraints

The company plans to double its investments in the next 2-3 years

Pharma, Healthcare stocks rise as defensive plays shine amid market volatility

Pharma stocks helped contain broader market losses on September 6, with increased investor interest in defensive plays like Glenmark Lifesciences and Suven Pharma.

Glenmark Life shares fall marginally post Ankleshwar facility closure notice

Glenmark Life Sciences Share Price | GPCB has ordered to deposit interim environment damage compensation as and when determined by GPCB.

Stock Radar: ICICI Bank, India Cements, BHEL, Biocon, REC, IndusInd Bank, UltraTech in focus on Monday

UltraTech Cement, Maruti Suzuki India, Sun Pharma Advanced Research Company, Glenmark Life Sciences, Hindustan Zinc, Godawari Power and Ispat, Manappuram Finance, Jubilant Pharmova, and Strides Pharma Science will also be in focus on Monday.

Glenmark Life Standalone June 2024 Net Sales at Rs 588.62 crore, up 1.76% Y-o-Y

Glenmark Life drops 4% on Glenmark Pharma's plans to exit via OFS

With this OFS, Glenmark Pharma will exit Glenmark Life Sciences. The floor price for the OFS sits at a 7.5 percent discount to the current market price of Glenmark Life Sciences.

Glenmark Life Sciences keeps up growth outlook in spite of Red Sea turmoil

Sales in March 2024 quarter declined by 13.6 percent amid shipment delays and logistics challenges

Glenmark Life Standalone March 2024 Net Sales at Rs 536.60 crore, down 13.64% Y-o-Y

Glenmark Life Standalone December 2023 Net Sales at Rs 572.80 crore, up 5.93% Y-o-Y

Nirma gets CCI nod for picking up majority stake in Glenmark Life Sciences

In September this year, Glenmark Pharmaceuticals said its board has approved to divest 75 per cent stake in its subsidiary GLS to Nirma Ltd for Rs 5,651.5 crore.

Glenmark Life Standalone September 2023 Net Sales at Rs 595.36 crore, up 16.9% Y-o-Y

A golden goose gone: Why Glenmark Pharma’s investors are unhappy with Nirma deal

Glenmark Pharma has hived off a 75 percent stake in Glenmark Life Sciences, which accounted for nearly 11 percent of its consolidated top line, and had a 20 percent EBITDA contribution, to clear debt

Glenmark Life Sciences deal to reduce parent’s debt, make it net cash positive: CMD

Saldhana added that the management of Glenmark Lifesciences will remain intact

Nirma makes big pharma push; acquires 75% in Glenmark Life Sciences for Rs 5,651 cr

With this acquisition, Nirma group founded by Dr Karsanbhai Patel has forayed into the API segment. Glenmark Pharma, the parent of Glenmark Life Sciences will use the deal proceeds towards repayment of debt

ChrysCapital joins race to buy Glenmark Life Sciences for around Rs 7,000 cr

The board of Glenmark Pharmaceuticals is said to take a decision regarding the sale soon and the amount received will be used to repay the debt of Rs 2,904 crore

Nirma to raise up to Rs 7,000 crore for acquisition, expansion of existing plants

Nirma has indicated that it will make large acquisitions in the domestic or overseas market to the tune of Rs 5,000-7,000 crore as part of its diversification plan.

Glenmark Life Standalone June 2023 Net Sales at Rs 578.45 crore, up 18.08% Y-o-Y

Glenmark faces a tough choice in API unit stake sale

The API subsidiary Glenmark Life Sciences (GLS) is trading at undemanding valuations and is yet to reach its full potential

Race for Glenmark Life Sciences: Blackstone, KKR, BPEA EQT, PAG and Nirma Group likely suitors

Glenmark Pharma, the parent company that holds 82.85% stake in Glenmark Life, is looking to reduce its debt burden via the stake sale process, say sources

Glenmark Life Standalone March 2023 Net Sales at Rs 621.32 crore, up 20.87% Y-o-Y

Glenmark Life hits 52-week high as strong Q4 earnings bolsters sentiment

Glenmark Life's strong growth in Q4 was on account of better margins driven by higher contribution from CDMO business, better product mix, PLI benefit and lower input costs

Top 10 trading ideas for next 3-4 weeks as bulls look charged up for third straight week

With the continuous nine-day winning streak, the support level continues to shift higher as we now see immediate support in the zone of 17,700 - 17,600; whereas 200-SMA around 17,500 is likely to act as a sacrosanct level

Glenmark Life Standalone December 2022 Net Sales at Rs 540.73 crore, up 3.49% Y-o-Y